Form 4: TuHURA Biosciences Director George Ng Acquires Options in Annual Grant
SEC Form 4 Filing
Director George Ng acquired 51,275 options in TuHURA Biosciences as part of the company's Non-Employee Director Compensation Program.
Summary
- George Ng, a director of TuHURA Biosciences, acquired 51,275 options on January 2, 2025.
- The options were granted as part of the Non-Employee Director Compensation Program.
- The exercise price of the options is $4.11.
- The options expire on January 2, 2035.
- One-third of the options become exercisable on the first, second, and third anniversaries of the grant date.
Sentiment
Score: 7
Explanation: Routine director compensation, indicating stability and alignment of interests.
Positives
- The option grant aligns the director's interests with those of the shareholders.
Industry Context
Option grants to directors are a common practice to incentivize and align their interests with the company's long-term performance.
Stakeholder Impact
- The option grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of the option grant and earliest transaction. |
| 01/02/2035 | Expiration date of the options. |
| 01/06/2025 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.